Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Journal of Breast Imaging
|
March 1, 2024
Breast Imaging During Pregnancy and Lactation
Lisa Abramson, Lindsey Massaro, J Jaime Alberty-Oller, et al.
Annals of Surgical Oncology
|
September 12, 2020
Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
J Jaime Alberty-Oller, Sarah Weltz, Antonio Santos, et al.
Cancer Reports (Hoboken, N.J.)
|
November 3, 2021
Does previous history of cancer or atypia predict histologic upgrade for pure intraductal papillomas diagnosed via core biopsy? A study of 490 cases at a single institution
J Jaime Alberty-Oller, Sylvia Reyes, Erin Moshier, et al.
Breast Cancer Research and Treatment
|
August 3, 2020
Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study
Michael Zeidman, J Jaime Alberty-Oller, Meng Ru, et al.
Breast Cancer Research and Treatment
|
January 4, 2021
Trends in neoadjuvant chemotherapy versus surgery-first in stage I HER2-positive breast cancer patients in the National Cancer DataBase (NCDB)
Michael Zeidman, Hank Schmidt, J Jaime Alberty-Oller, et al.
JCO Precision Oncology
|
June 24, 2026
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study
Joyce O'Shaughnessy, Adam M Brufsky, Rakhshanda Layeequr Rahman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Journal of Breast Imaging
|
March 1, 2024
Breast Imaging During Pregnancy and Lactation
Lisa Abramson, Lindsey Massaro, J Jaime Alberty-Oller, et al.
Annals of Surgical Oncology
|
September 12, 2020
Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
J Jaime Alberty-Oller, Sarah Weltz, Antonio Santos, et al.
Cancer Reports (Hoboken, N.J.)
|
November 3, 2021
Does previous history of cancer or atypia predict histologic upgrade for pure intraductal papillomas diagnosed via core biopsy? A study of 490 cases at a single institution
J Jaime Alberty-Oller, Sylvia Reyes, Erin Moshier, et al.
Breast Cancer Research and Treatment
|
August 3, 2020
Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study
Michael Zeidman, J Jaime Alberty-Oller, Meng Ru, et al.
Breast Cancer Research and Treatment
|
January 4, 2021
Trends in neoadjuvant chemotherapy versus surgery-first in stage I HER2-positive breast cancer patients in the National Cancer DataBase (NCDB)
Michael Zeidman, Hank Schmidt, J Jaime Alberty-Oller, et al.
JCO Precision Oncology
|
June 24, 2026
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study
Joyce O'Shaughnessy, Adam M Brufsky, Rakhshanda Layeequr Rahman, et al.
Page
of 1